These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 22313751)
21. Losartan improves erectile dysfunction in diabetic patients: a clinical trial. Chen Y; Cui S; Lin H; Xu Z; Zhu W; Shi L; Yang R; Wang R; Dai Y Int J Impot Res; 2012; 24(6):217-20. PubMed ID: 22931760 [TBL] [Abstract][Full Text] [Related]
22. Low Intensity Extracorporeal Shock Wave Therapy Improves Erectile Function in a Model of Type II Diabetes Independently of NO/cGMP Pathway. Assaly-Kaddoum R; Giuliano F; Laurin M; Gorny D; Kergoat M; Bernabé J; Vardi Y; Alexandre L; Behr-Roussel D J Urol; 2016 Sep; 196(3):950-6. PubMed ID: 27038770 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat. de Tejada IS Int J Impot Res; 2004 Jun; 16 Suppl 1():S40-2. PubMed ID: 15224136 [TBL] [Abstract][Full Text] [Related]
24. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil. Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674 [TBL] [Abstract][Full Text] [Related]
25. [Xiongcan Yishen Prescription upregulates the expressions of eNOS and cGMP in the penile tissue of ED rats with liver depression and kidney deficiency]. Li BN; Zhou HL; Xiao D; He QH; Zhou X Zhonghua Nan Ke Xue; 2020 Feb; 26(2):167-173. PubMed ID: 33346422 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of Danshen injection against erectile dysfunction via suppression of endoplasmic reticulum stress activation in a streptozotocin-induced diabetic rat model. Zhang Y; Chen J; Ji H; Xiao ZG; Shen P; Xu LH BMC Complement Altern Med; 2018 Dec; 18(1):343. PubMed ID: 30587186 [TBL] [Abstract][Full Text] [Related]
27. Protective effects of hydrogen-rich saline against erectile dysfunction in a streptozotocin induced diabetic rat model. Fan M; Xu X; He X; Chen L; Qian L; Liu J; Qing J; Chao Z; Sun X J Urol; 2013 Jul; 190(1):350-6. PubMed ID: 23220246 [TBL] [Abstract][Full Text] [Related]
28. Effect of icarisid II on diabetic rats with erectile dysfunction and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO-cGMP pathway. Zhang J; Li AM; Liu BX; Han F; Liu F; Sun SP; Li X; Cui SJ; Xian SZ; Kong GQ; Xin ZC; Ji ZL Asian J Androl; 2013 Jan; 15(1):143-8. PubMed ID: 22728670 [TBL] [Abstract][Full Text] [Related]
29. S-allyl cysteine restores erectile function through inhibition of reactive oxygen species generation in diabetic rats. Yang J; Wang T; Yang J; Rao K; Zhan Y; Chen RB; Liu Z; Li MC; Zhuan L; Zang GH; Guo SM; Xu H; Wang SG; Liu JH; Ye ZQ Andrology; 2013 May; 1(3):487-94. PubMed ID: 23427186 [TBL] [Abstract][Full Text] [Related]
30. Nitro-oleic acid ameliorates erectile dysfunction in a streptozotocin-induced rat model of diabetes by inhibiting oxidative stress and apoptosis and activating the NO/cGMP pathway. Zhao CB; Chen WB; Wang WZ; Gong FX; Fan CQ; Li Y; Lan T; Wang WJ; Yuan MZ Asian J Androl; 2024 Jan; 26(1):57-66. PubMed ID: 37695220 [TBL] [Abstract][Full Text] [Related]
32. Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats. Zhang W; Wang Y; Yang Z; Qiu J; Ma J; Zhao Z; Bao T J Biosci Bioeng; 2011 Sep; 112(3):215-8. PubMed ID: 21664865 [TBL] [Abstract][Full Text] [Related]
33. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603 [TBL] [Abstract][Full Text] [Related]
35. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Pegge NC; Twomey AM; Vaughton K; Gravenor MB; Ramsey MW; Price DE Diabet Med; 2006 Aug; 23(8):873-8. PubMed ID: 16911625 [TBL] [Abstract][Full Text] [Related]
37. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway. Reilly CM; Lewis RW; Stopper VS; Mills TM J Androl; 1997; 18(6):588-94. PubMed ID: 9432131 [TBL] [Abstract][Full Text] [Related]
38. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Boolell M; Allen MJ; Ballard SA; Gepi-Attee S; Muirhead GJ; Naylor AM; Osterloh IH; Gingell C Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389 [TBL] [Abstract][Full Text] [Related]
40. PKC Inhibition Improves Human Penile Vascular Function and the NO/cGMP Pathway in Diabetic Erectile Dysfunction: The Role of NADPH Oxidase. El Assar M; La Fuente JM; Sosa P; Fernández A; Pepe-Cardoso AJ; Martínez-Salamanca JI; Rodríguez-Mañas L; Angulo J Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]